Skip to main content

Take Action for NF2-SWN

Driving Awareness & Fueling Research for NF2-SWN

Welcome families, friends, and supporters of those living with NF2-related schwannomatosis (NF2-SWN). Together, we’re raising awareness and driving donations to fuel research and provide vital support for the NF2-SWN community.

To give directly to NF2-SWN research, use this button.

Donate

CTF NF Ambassador: Leanna Scaglione

Diagnosed with NF2-related schwannomatosis at 16 after a spinal tumor ended her ballet aspirations, Leanna has faced numerous challenges, including multiple surgeries, hearing loss, and facial paralysis. Despite these hurdles, she has become a passionate advocate and endurance athlete, using her experiences to raise awareness and inspire others. Through her involvement with the NF Endurance team, Leanna demonstrates unwavering resilience, proving that determination can overcome adversity.

Our Commitment to NF2-SWN: Backed by Action

At the Children’s Tumor Foundation, we recognize the urgency and unmet needs of those living with NF2-related schwannomatosis. That’s why we’ve committed over $2.5 million across 14 active research grants focused exclusively on NF2-SWN. These projects span clinical trials, drug discovery, quality of life, and foundational science — each one selected for its potential to lead to better treatments, faster.

CTF’s NF2-SWN Research Portfolio
$2.5 Million in Funding Across 14 Active Grants

Coming Soon!

Breakthrough for NF2-SWN: Brigatinib

CTF’s team uncovered and fast-tracked Brigatinib as a potential treatment in the first NF platform clinical trial, which is showing great promise. Read more below, or watch the webinar about treatments in progress for NF2-SWN.

Read MoreWebinar
Two scientists in lab coats and masks work near a microscope in a laboratory setting.